Log in to save to my catalogue

High prevalence of persistent residual parasitemia on days 3 and 14 after artemether–lumefantrine or...

High prevalence of persistent residual parasitemia on days 3 and 14 after artemether–lumefantrine or...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2754048530

High prevalence of persistent residual parasitemia on days 3 and 14 after artemether–lumefantrine or pyronaridine–artesunate treatment of uncomplicated Plasmodium falciparum malaria in Nigeria

About this item

Full title

High prevalence of persistent residual parasitemia on days 3 and 14 after artemether–lumefantrine or pyronaridine–artesunate treatment of uncomplicated Plasmodium falciparum malaria in Nigeria

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Parasitology research (1987), 2023-02, Vol.122 (2), p.519-526

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Background
Microscopic evaluation of parasite clearance is the gold standard in antimalarial drug efficacy trials. However, the presence of sub-microscopic residual parasitemia after artemisinin-based combination therapy (ACT) needs to be investigated.
Methods
One hundred and twenty (AL:
n
 = 60, PA:
n
 = 60) days 3 and 14 drie...

Alternative Titles

Full title

High prevalence of persistent residual parasitemia on days 3 and 14 after artemether–lumefantrine or pyronaridine–artesunate treatment of uncomplicated Plasmodium falciparum malaria in Nigeria

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2754048530

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2754048530

Other Identifiers

ISSN

0932-0113

E-ISSN

1432-1955

DOI

10.1007/s00436-022-07753-8

How to access this item